Veliz A, Hughes L, Carrillo D, Pecaut M, Kearns-Jonker M
BMC Genomics. 2025; 26(1):229.
PMID: 40065216
PMC: 11892206.
DOI: 10.1186/s12864-025-11426-y.
Wiger C, Ranheim T, Arnesen H, Vaage J, Pischke S, Yndestad A
Immun Inflamm Dis. 2025; 13(1):e70133.
PMID: 39853914
PMC: 11760985.
DOI: 10.1002/iid3.70133.
Golino M, Harding D, Del Buono M, Fanti S, Mohiddin S, Toldo S
Int J Cardiol. 2024; 404:131901.
PMID: 38403204
PMC: 11450758.
DOI: 10.1016/j.ijcard.2024.131901.
Le Quilliec E, Fundere A, Al-Udatt D, Hiram R
Biomedicines. 2023; 11(9).
PMID: 37760868
PMC: 10525278.
DOI: 10.3390/biomedicines11092427.
Dutta A, Das M, Ghosh A, Rana S
Genes Dis. 2023; 10(3):948-959.
PMID: 37396513
PMC: 10308167.
DOI: 10.1016/j.gendis.2022.08.008.
TLR4-A Pertinent Player in Radiation-Induced Heart Disease?.
Gawali B, Sridharan V, Krager K, Boerma M, Pawar S
Genes (Basel). 2023; 14(5).
PMID: 37239362
PMC: 10218711.
DOI: 10.3390/genes14051002.
Identification of potential biomarkers of inflammation-related genes for ischemic cardiomyopathy.
Wang J, Xie S, Cheng Y, Li X, Chen J, Zhu M
Front Cardiovasc Med. 2022; 9:972274.
PMID: 36082132
PMC: 9445158.
DOI: 10.3389/fcvm.2022.972274.
Potential therapeutic strategies for myocardial infarction: the role of Toll-like receptors.
Komal S, Komal N, Mujtaba A, Wang S, Zhang L, Han S
Immunol Res. 2022; 70(5):607-623.
PMID: 35608723
DOI: 10.1007/s12026-022-09290-z.
Reperfusion Cardiac Injury: Receptors and the Signaling Mechanisms.
Maslov L, Popov S, Mukhomedzyanov A, Naryzhnaya N, Voronkov N, Ryabov V
Curr Cardiol Rev. 2022; 18(5):63-79.
PMID: 35422224
PMC: 9896422.
DOI: 10.2174/1573403X18666220413121730.
Characterization of Transverse Aortic Constriction in Mice Based on the Specific Recruitment of Leukocytes to the Hypertrophic Myocardium and the Aorta Ascendens.
Kleiner J, Kopke O, Faron A, Zhang Y, Cornelssen J, Coburn M
Mediators Inflamm. 2021; 2021:1376859.
PMID: 34776787
PMC: 8580661.
DOI: 10.1155/2021/1376859.
Pro-inflammatory cytokines as emerging molecular determinants in cardiolaminopathies.
Gerbino A, Forleo C, Milano S, Piccapane F, Procino G, Pepe M
J Cell Mol Med. 2021; 25(23):10902-10915.
PMID: 34773379
PMC: 8642682.
DOI: 10.1111/jcmm.16975.
RhoA Signaling in Immune Cell Response and Cardiac Disease.
Kilian L, Frank D, Rangrez A
Cells. 2021; 10(7).
PMID: 34359851
PMC: 8306393.
DOI: 10.3390/cells10071681.
YAP/TEAD1 Complex Is a Default Repressor of Cardiac Toll-Like Receptor Genes.
Gao Y, Sun Y, Ercan-Sencicek A, King J, Akerberg B, Ma Q
Int J Mol Sci. 2021; 22(13).
PMID: 34206257
PMC: 8268263.
DOI: 10.3390/ijms22136649.
Toll-Like Receptors: Are They Taking a Toll on the Heart in Viral Myocarditis?.
Favere K, Bosman M, Klingel K, Heymans S, Van Linthout S, Delputte P
Viruses. 2021; 13(6).
PMID: 34072044
PMC: 8227433.
DOI: 10.3390/v13061003.
Can the calcium-regulating hormones counteract the detrimental impact of pro-inflammatory damage-associated molecular patterns in the development of heart failure?.
Adamyan S, Harutyunyan K, Abrahamyan H, Khudaverdyan D, Mkrtchian S, Ter-Markosyan A
J Investig Med. 2021; 69(6):1148-1152.
PMID: 33952612
PMC: 8327405.
DOI: 10.1136/jim-2020-001754.
RhoA: a dubious molecule in cardiac pathophysiology.
Kilian L, Voran J, Frank D, Rangrez A
J Biomed Sci. 2021; 28(1):33.
PMID: 33906663
PMC: 8080415.
DOI: 10.1186/s12929-021-00730-w.
Dexmedetomidine attenuates myocardial ischemia-reperfusion injury in vitro by inhibiting NLRP3 Inflammasome activation.
Huang Y, Sun X, Juan Z, Zhang R, Wang R, Meng S
BMC Anesthesiol. 2021; 21(1):104.
PMID: 33823789
PMC: 8022424.
DOI: 10.1186/s12871-021-01334-5.
The pivotal roles of exosomes derived from endogenous immune cells and exogenous stem cells in myocardial repair after acute myocardial infarction.
Xiong Y, Gong Z, Tang R, Yang Y
Theranostics. 2021; 11(3):1046-1058.
PMID: 33391520
PMC: 7738892.
DOI: 10.7150/thno.53326.
Innate Immune Receptors, Key Actors in Cardiovascular Diseases.
Jaen R, Val-Blasco A, Prieto P, Gil-Fernandez M, Smani T, Lopez-Sendon J
JACC Basic Transl Sci. 2020; 5(7):735-749.
PMID: 32760860
PMC: 7393405.
DOI: 10.1016/j.jacbts.2020.03.015.
High-mobility group Box-1 regulates acute myocardial ischemia-induced injury through the toll-like receptor 4-related pathway.
Bai C, Ren Y, Huang J, Zhang Y, Li L, Du G
Int J Clin Exp Pathol. 2020; 10(8):8344-8352.
PMID: 31966685
PMC: 6965424.